Cite
HARVARD Citation
Yu, J. et al. (2022). Risk of hepato‐pancreato‐biliary cancer is increased by primary sclerosing cholangitis in patients with inflammatory bowel disease: A population‐based cohort study. United European Gastroenterology journal. 10 (2), pp. 212-224. [Online].